So, talking about Medtronic and Endurant and Endurant II, with that now in the market place, can we talk as to how the competitive environment in your mind has changed in the last 12 and 24 months, specifically with Endurant and if you think about, and obviously it is much further in the future but with TriVascular, maybe several years in the future, how does the competitive environment for you transform last year and the next two years?
Endologix's CEO Presents At Morgan Stanley Healthcare Conference (Transcript)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts